Literature DB >> 6739222

Pineal region tumors of childhood.

R J Packer, L N Sutton, J G Rosenstock, L B Rorke, L T Bilaniuk, R A Zimmerman, P A Littman, D A Bruce, L Schut.   

Abstract

The incidence, response to treatment, and outcome of children with pineal region neoplasms is poorly characterized. Since 1975, in one institution, 25 consecutive patients with pineal tumors have undergone biopsy prior to further treatment. This constituted 11% (25/234) of all brain neoplasms seen over this time period. Specific tumors diagnosed included pineal parenchymal tumors ( pineoblastomas , pineocytomas ) in eight patients (32%); germ cell tumors (embryonal cell carcinomas, teratomas, germinomas) in eight patients (32%); glial tumors (astrocytoma, ganglioglioma ) in eight patients (32%); and ganglioneuroblastoma in one patient (4%). Clinical parameters, computed tomographic findings and CSF markers (alphafetoprotein and human chorionic gonadotropin) were unreliable in discriminating between specific tumor types. Response to treatment and patterns of disease relapse were dependent on the type of tumor present. Five of eight children with pineal parenchymal tumors had disease recurrence, and in all leptomeningeal dissemination occurred prior to or concurrent with local relapse. Three of eight children with germ cell tumors and two of eight patients with glial tumors suffered a relapse; in all five children recurrence was initially local. Findings suggest that pineal region neoplasms are not infrequent in childhood; that these tumors vary greatly in histologic type; that contrary to other reports germinomas do not constitute the majority of pineal tumors; and that histologic confirmation is necessary prior to treatment for appropriate management.

Entities:  

Mesh:

Year:  1984        PMID: 6739222

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy.

Authors:  P L Robertson; R C DaRosso; J C Allen
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Pineal ganglioneuroblastoma in an adult.

Authors:  M Tanaka; S Shibui; K Nomura; Y Nakanishi
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

3.  Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.

Authors:  Matthew D Stephen; Peter E Zage; Steven G Waguespack
Journal:  Int J Pediatr Endocrinol       Date:  2011-03-06

4.  Pineal ganglioglioma with premature thelarche. Report of a case and review of the literature.

Authors:  Y L Chang; S Z Lin; Y H Chiang; M Y Liu; W H Lee
Journal:  Childs Nerv Syst       Date:  1996-02       Impact factor: 1.475

5.  Pineal tumours in the north of England 1968-93.

Authors:  S Bailey; R Skinner; H H Lucraft; R H Perry; N Todd; A D Pearson
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

6.  Pineal region tumours of childhood.

Authors:  F J Schulte; H D Herrmann; D Müller; H Franke; W Saeger; F W Spaar; S Bartels
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

7.  Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG).

Authors:  L White; H Johnston; R Jones; H Mameghan; V Nayanar; W McWhirter; S Kellie; K Waters; I Toogood
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Brain tumours in children. A plea for an interdisciplinary working group.

Authors:  F J Schulte; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

9.  Brain stem necrosis after preradiation high-dose methotrexate.

Authors:  R J Packer; R I Grossman; L B Rorke; L N Sutton; K R Siegel; P Littman
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

10.  Pineal gland tumors: experience from the SEER database.

Authors:  Maysa Al-Hussaini; Iyad Sultan; Najyah Abuirmileh; Imad Jaradat; Ibrahim Qaddoumi
Journal:  J Neurooncol       Date:  2009-04-17       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.